{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:10:22Z","timestamp":1762409422829,"version":"3.40.5"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jpba.2018.04.027","type":"journal-article","created":{"date-parts":[[2018,4,22]],"date-time":"2018-04-22T16:56:10Z","timestamp":1524416170000},"page":"147-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["New approach based on immunochemical techniques for monitoring of selective estrogen receptor modulators (SERMs) in human urine"],"prefix":"10.1016","volume":"156","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3608-0634","authenticated-orcid":false,"given":"J.-Pablo","family":"Salvador","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Vila-Roca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00faria","family":"Monfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4064-1668","authenticated-orcid":false,"given":"M.-Pilar","family":"Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24 Supplement","key":"10.1016\/j.jpba.2018.04.027_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/0008-5472.SABCS-09-33","article-title":"Adjuvant tamoxifen treatment outcome according to cytochrome P450 2D6 (CYP2D6) phenotype in early stage Breast cancer: findings from the international tamoxifen pharmacogenomics consortium","volume":"69","author":"Goetz","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.jpba.2018.04.027_bib0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/bjp.2008.150","article-title":"Indirect androgen doping by oestrogen blockade in sports","volume":"154","author":"Handelsman","year":"2008","journal-title":"Br. J. Pharmacol."},{"year":"2015","series-title":"Minimum Required Performance Levels for Detection and Identification of Non-threshold Substances","author":"WADA","key":"10.1016\/j.jpba.2018.04.027_bib0015"},{"issue":"29","key":"10.1016\/j.jpba.2018.04.027_bib0020","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.chroma.2011.05.073","article-title":"Mass spectrometric characterization of urinary toremifene metabolites for doping control analyses","volume":"1218","author":"G\u00f3mez","year":"2011","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.jpba.2018.04.027_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09674845.2014.11669960","article-title":"Evaluation of tamoxifen and metabolites by LC-MS\/MS and HPLC methods","volume":"71","author":"Heath","year":"2014","journal-title":"Br. J. Biomed. Sci."},{"issue":"24","key":"10.1016\/j.jpba.2018.04.027_bib0030","doi-asserted-by":"crossref","first-page":"7497","DOI":"10.1007\/s00216-015-8907-8","article-title":"Highly sensitive simultaneous quantification of estrogenic tamoxifen metabolites and steroid hormones by LC-MS\/MS","volume":"407","author":"Johaenning","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"issue":"16","key":"10.1016\/j.jpba.2018.04.027_bib0035","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1007\/s00216-013-6961-7","article-title":"Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS\/(MS) following in vitro and excretion studies","volume":"405","author":"Mazzarino","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"issue":"3","key":"10.1016\/j.jpba.2018.04.027_bib0040","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1255\/ejms.921","article-title":"A mass spectrometric approach for the study of the metabolism of clomiphene, tamoxifen and toremifene by liquid chromatography time-of-flight spectroscopy","volume":"14","author":"Mazzarino","year":"2008","journal-title":"Eur. J. Mass Spectrom."},{"key":"10.1016\/j.jpba.2018.04.027_bib0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/b98609","article-title":"Immunochemical determination of industrial emerging pollutants","author":"Est\u00e9vez","year":"2005","journal-title":"Water Pollut."},{"key":"10.1016\/j.jpba.2018.04.027_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/b98616","article-title":"Immunochemical determination of pharmaceuticals and personal care products as emerging pollutants","author":"Est\u00e9vez","year":"2005","journal-title":"Water Pollut."},{"issue":"10","key":"10.1016\/j.jpba.2018.04.027_bib0055","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1021\/ac061757x","article-title":"Preparation of antibodies for the designer steroid tetrahydrogestrinone and development of an enzyme-linked immunosorbent assay for human urine analysis","volume":"79","author":"Salvador","year":"2007","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2018.04.027_bib0060","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ab.2008.02.009","article-title":"Simultaneous immunochemical detection of stanozolol and the main human metabolite, 3'-hydroxy-stanozolol, in urine and serum samples","volume":"376","author":"Salvador","year":"2008","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.jpba.2018.04.027_bib0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jchromb.2009.08.027","article-title":"A high-throughput screening (HTS) immunochemical method for the analysis of stanozolol metabolites in cattle urine samples","volume":"878","author":"Salvador","year":"2010","journal-title":"J. Chromatogr. B"},{"issue":"2","key":"10.1016\/j.jpba.2018.04.027_bib0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.msec.2012.09.021","article-title":"Detection of anticancer drug tamoxifen using biosensor based on polyaniline probe modified with horseradish peroxidase","volume":"33","author":"Radhapyari","year":"2013","journal-title":"Mater. Sci. Eng.: C"},{"issue":"1","key":"10.1016\/j.jpba.2018.04.027_bib0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0960-0760(02)00046-8","article-title":"Estrogen receptor binding assay of chemicals with a surface plasmon resonance biosensor","volume":"81","author":"Usami","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.jpba.2018.04.027_bib0080","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1021\/jo952279l","article-title":"New highly stereoselective synthesis of (Z)-4-Hydroxytamoxifen and (Z)-4-Hydroxytoremifene via McMurry reaction","volume":"61","author":"Gauthier","year":"1996","journal-title":"J. Org. Chem."},{"issue":"24","key":"10.1016\/j.jpba.2018.04.027_bib0085","doi-asserted-by":"crossref","first-page":"9489","DOI":"10.1021\/jo035164n","article-title":"Simple and efficient production of (Z)-4-Hydroxytamoxifen, a potent estrogen receptor modulator","volume":"68","author":"Yu","year":"2003","journal-title":"J. Org. Chem."},{"issue":"8","key":"10.1016\/j.jpba.2018.04.027_bib0090","first-page":"2175","article-title":"Distribution of 4-Hydroxy-N-desmethyltamoxifen and other tamoxifen metabolites in human biological fluids during tamoxifen treatment","volume":"49","author":"Lien","year":"1989","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jpba.2018.04.027_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0022-1759(86)90497-7","article-title":"Hapten-protein conjugates prepared by the mixed anhydride method: cross-reactive antibodies in heterologous antisera","volume":"92","author":"Gendloff","year":"1986","journal-title":"J. Immunol. Methods"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518302048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518302048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T05:20:33Z","timestamp":1534915233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518302048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":19,"alternative-id":["S0731708518302048"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.04.027","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New approach based on immunochemical techniques for monitoring of selective estrogen receptor modulators (SERMs) in human urine","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}